Background. The objective of this study was to elucidate the relation between respiratory syncytial virus (RSV) infection and cytokine/chemokine concentrations, as well as the impact that these factors have on the severity of bronchiolitis.
wheezing, and/or difficulty in breathing). Hospitalizations for bronchiolitis have increased substantially during recent years, and the disease is the number one health problem in infants in the United States [1, 2] ; ∼300,000 children are hospitalized annually because of it [3] . Fifteen percent of hospitalized children receive care in the intensive-care unit, and 50% of them require mechanical ventilation [4] .
RSV, the pathogen most common in bronchiolitis, is the culprit in 43%-90% of cases of the disease [2, 4, [5] [6] [7] . Worldwide, RSV is the most common pathogen in LRT disease in children in developed and developing countries and is responsible for a significant disease burden [5, 8] .
The impact that cytokines and chemokines have on the severity of RSV bronchiolitis has not been clearly elucidated. Previous investigations have implicated an imbalanced immune response [9, 10] and specific inflammatory mediators [11, 12] as contributors to the severity of disease. Cytokines with potent antiviral activities have been associated with protection against severe bronchiolitis [9, 10, [13] [14] [15] [16] [17] . We recently reported that children who presented to the emergency department (ED) with bronchiolitis and who subsequently were discharged home had significantly higher levels of proinflammatory mediators in nasal secretions than did children with bronchiolitis who were admitted to the hospital. Both proinflammatory and anti-inflammatory mediators have been shown to be present in the context of RSV infection [18, 19] ; the clinical expression of RSV is likely, in part, the result of these opposing immune responses.
The objective of the present study was to define the specific inflammatory pattern associated with RSV bronchiolitis and to compare it with that associated with non-RSV bronchiolitis. On the basis of previous investigations [20] [21] [22] , we hypothesized that RSV infection would elicit a greater inflammatory response than would non-RSV bronchiolitis-and, in addition, that this unique inflammatory pattern for RSV infection would be associated with more-severe bronchiolitis.
SUBJECTS, MATERIALS, AND METHODS
Study design. The investigation was a prospective cohort study of children !24 months old who presented, with signs and symptoms of bronchiolitis, to the ED at Texas Children's Hospital during an RSV outbreak. Any child, regardless of health status, was eligible for enrollment if he or she was !24 months old and had signs of bronchiolitis (defined as lowerairway disease with tachypnea, crackles, wheezing, and/or retractions) and a history of previous upper-airway infection (defined as nasal congestion and/or rhinorrhea). Children who presented with respiratory distress unrelated to a viral-like respiratory illness were excluded. Before the start of the study, approval was obtained from the institutional review board.
Children who qualified for the study were enrolled in the ED after the parents gave informed consent. At enrollment, demographic and clinical information was obtained, a physical examination performed, and a nasal-wash sample was collected for virus identification, analysis of RSV concentration, and identification of inflammatory mediators. The information and sample were obtained by an investigator not associated with either the disposition of or the plan for treatment of the child. The outcome of the bronchiolitis event (i.e., child was discharged home, hospitalized, or treated with supplemental oxygen, intravenous fluid [IVF] , and/or mechanical ventilation) was subsequently identified by a review of the medical records.
Sample collection. During the child's visit to the ED, a nasal-wash sample was collected by instilling 2 mL of normal saline into one of the external nares and then, via flexible rubber tubing, aspirating the material back into the syringe containing 2 mL of normal saline. The sample was then added to transport medium with a virus stabilizer (15% glycerol in Iscove's media), in a 1:1 dilution. Each nasal-wash sample contained 6-8 mL of diluted nasal-wash sample. The samples were refrigerated at 4ЊC for р72 h. Four to six 1-1.5-mL aliquots per nasal-wash sample were prepared, snap-frozen, and stored at Ϫ70Њ C. They were then processed for isolation and quantification of virus and for quantification of cytokines and chemokines [23] [24] [25] [26] [27] [28] [29] .
Virus isolation. For the isolation and identification of respiratory viruses, samples were inoculated onto of HEp-2 (human epithelial carcinoma), LLC-MK2 (monkey kidney), rhesus-monkey kidney (RhMK), and WI-38 (human fibroblast cells) tissue-culture tubes, as described elsewhere [23] . Medium containing trypsin but lacking fetal calf serum was required for isolation of influenza viruses and human metapneumovirus (HMPV) [24] . Samples positive for both viral-like cytopathic effect (CPE) and hemagglutinin were tested for the presence of RSV, parainfluenza viruses, and adenovirus, by use of a virusspecific monoclonal antibody (Trinity Biotech), and then were stained with fluorescein-conjugated secondary antibody. Picornavirus was identified on the basis of typical CPE in WI-38 cells [25] [26] [27] . At 3 weeks, LLC-MK2 cultures were passed blindly onto samples of fresh LLC-MK2, for isolation of HMPV. Reverse-transcriptase polymerase chain reaction was used for identification of HMPV and for confirmation of the presence of influenza A (strains H1N1 and H3N2), influenza B, and RSV [25, 26, 28] .
RSV quantification. To quantify RSV concentration in nasal secretions, all samples were titrated in a plaque assay, as described in previous reports from our laboratory [23, 24] . Duplicate samples underwent serial 10-fold dilutions (10 0 -10 Ϫ5 ). The lower limit of detection was 10 pfu/mL. The RSV concentration for all RSV-positive samples was adjusted by a factor of 4, to account for the dilution caused by the nasalwash collection method. An RSV-positive standard ( 6 2.6 ϫ 10 pfu/mL) was analyzed along with each test batch.
Cytokine/chemokine analysis. Nasal-wash samples were tested, according to the manufacturer's instructions, by use of a Bioplex Human Cytokine 17-Plex panel, which includes interleukin (IL)-1B, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, IL-17, granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon (IFN)-g, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1B, and tumor necrosis factor (TNF)-a (Bio-Rad Laboratories). Samples and serial dilutions of the cytokine standards (50 mL) were incubated with anti-human cytokine-coated beads in a 96-well filtration plate. After primary and secondary antibody treatment, the samples were resuspended in assay buffer (Bio-Rad), and 100 beads of each cytokine were acquired and analyzed by use of the Luminex-based Bio-Plex Suspension Array System (Bio-Rad) [29] . The lower limit of detection for all cytokines (27) .07 Comorbid conditions .31
NOTE. Data are no. (%) of children. x 2 , Fisher's exact, and Mann-Whitney U tests were used to determine differences between groups.
was considered to be significant. P р .05
and chemokines was 1 pg/mL; samples with cytokine/chemokine values !1 pg/mL were assigned a value of 0 pg/mL. Statistical analysis. Severe cases of RSV bronchiolitis were defined as those requiring hospitalization, and severity of the disease was further determined on the basis of the expected duration of supplemental-oxygen therapy and/or IVF therapy. The decision regarding the need for hospitalization was made by the primary-care physician in the ED, and the estimation of the expected duration of the 2 types of therapy was made by the primary-care physician in the hospital, neither of whom was involved in collection or analysis of the data.
The child's age in months was recorded and was used to classify each child as belonging to 1 of 4 age groups-0р3 months, 3р6 months, 6р12 months, and 12р24 monthsfor clinical and biological relevance. Also, the duration of illness at the time of presentation, defined as the number of days that the child had had the current illness before presenting to the ED, was used to classify each child as belonging 1 of 5 groups-1-2 days, 3-4 days, 5-6 days, 7-10 days, and 110 days-to facilitate statistical analysis.
Data on the descriptive characteristics of the children were analyzed by use of x 2 , Fisher's exact, and Mann-Whitney U tests. Analysis of variance was used to analyze viral load with respect to the duration of illness. Nonparametric tests and median values were used for those variables-such as age, duration of illness, and cytokine/chemokine concentrations-that were not normally distributed. Spearman's r was used for the correlation analyses. Linear regression analysis was used to evaluate the impact that the time between the collection and the freezing of samples had on RSV load and cytokine concentration. IL-8 was chosen as a representative cytokine because of its consistent results with multiple outcomes (data not shown). For all outcomes and relations between variables, differences between groups were considered statistically significant at P р . SPSS (version 14.0) for Windows was used for all analyses. .05 
RESULTS

Enrollment and characteristics of the children. Between 1 November 2004 and 28 February 2005
, a 17-week period that encompassed the RSV season in the hospital's geographic area, 101 children were enrolled at the ED at Texas Children's Hospital, via a convenience sample. Enrollment occurred during daytime, evening, and overnight shifts, in the main ED and in the urgent-care clinic. A total of 99 children were included for analysis (1 child did not meet inclusion criteria, and consent to enroll 1 other child was withdrawn). The nasal-wash sample from 1 child was lost during transport; however, the child's clinical information was retained. Clinical data-collection sheets for 2 children were lost; however, their laboratory data were retained. Thus, both nasal-wash samples and clinical information on 96 of the 99 children with bronchiolitis were available. The total numbers of children in the analyses reflect the missing data.
A specific viral etiology was determined in 76 (78%) of the 98 enrolled children for whom nasal-wash samples were available: 63 of them were infected with RSV (51 were infected with RSV A, and 12 were infected with RSV B); 13 were infected with other respiratory viruses (5 were infected with picornavirus, 3 were infected with adenovirus, 2 were infected with HMPV, 1 was infected with cytomegalovirus, 1 was infected with influenza B, and 1 was infected with parainfluenza virus). In the remaining 22 children who had clinical signs and symptoms of bronchiolitis (e.g., lower-airway disease with tachypnea, crackles, wheezing, or retractions combined with a history of previous upper-airway infection), no virus was detected.
Linear regression analysis was used to evaluate the impact that the time between the collection and the freezing of samples had on RSV load and IL-8 concentration; the P values were .91 and .66, respectively, indicating that the time between collection and freezing did not significantly impact the results. The percent positivity was also comparable between 93 samples that were processed within 24-72 h after collection. In these samples, a virus was detected in 79%, 85%, and 78% in the samples that were frozen after 24, 48, and 72 hours of refrigeration, respectively.
With respect to the need for hospitalization, supplementaloxygen therapy for 124 h, or IVF therapy for 124 h, there were no differences between the group of children with RSV A strains and the group of children with RSV B strains (data not shown). Therefore, RSV-positive children were analyzed as a single group and were not divided with respect to RSV strain.
The children's characteristics with respect to RSV status are shown in table 1. Children in the present who were exposed to children (either a sibling or a child in the same day-care group) !5 years old were more likely to have an RSV infection ( ). A higher male:female ratio was observed in both P p .07 groups. There was no significant difference in RSV status of children with a personal or family history of wheezing, of children exposed to tobacco smoke or day care alone, or of children with other comorbidities. Congenital heart disease was present in 4 children, none of whom were infected with RSV; 2 of these 4 had received Synagis.
Impact of age-on viral infection and on severity of disease. The impact that age has on viral infection and on the severity of bronchiolitis was investigated. The age of a child was inversely associated with that child's need for hospitalization ( ): infants !6 months old were significantly more likely P ! .05 to be RSV positive than were older children (
). There P ! .05 was a significant positive correlation between age in months and RSV concentration ( [ ]). The 5 age groups r p .26 P p .04 were not significantly different with respect to the duration of illness at the time of presentation, supplemental-oxygen therapy for 124 h, IVF therapy for 124 h, intubation, tachypnea, or identification of viral etiology (table 2) .
RSV status. Age, clinical outcome, and innate immune response were compared in children with RSV bronchiolitis ver- NOTE. The Mann-Whitney U test was used to determine differences between groups. G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; IQR, interquartile range (25th percentile through 75th percentile); MCP, monocyte chemoattractant protein; MIP, macrophage inflammatory protein; TNF, tumor necrosis factor. sus children with non-RSV bronchiolitis (table 3). Severe cases of disease, which were defined as those that required hospitalization and which were further quantified on the basis of the duration of supplemental-oxygen therapy and/or IVF therapy, were not significantly more frequent in children with RSV bronchiolitis than they were in children with non-RSV bronchiolitis. The levels of all detectable (у1 pg/mL) cytokines and chemokines except for IL-2 were significantly higher in children with RSV bronchiolitis than in those with non-RSV bronchiolitis.
RSV bronchiolitis, inflammatory mediators, and severity of disease. The relation between nasal-wash cytokine/chemokine concentrations and the severity of disease in children with RSV bronchiolitis was also evaluated, on the basis of the need for hospitalization, the duration of supplemental-oxygen therapy, and the duration of IVF therapy. Cytokine/chemokine levels were not significantly different with respect to the need for hospitalization or the duration of IVF therapy; however, the levels of IL-6, IL-8, IL-10, IFN-g, and MIP-1b were significantly inversely associated with the duration of supplemental-oxygen therapy (table 4) .
RSV load, inflammatory mediators, and duration of illness. To evaluate the temporal relation between viral infection and the evolution of disease, we analyzed nasal-wash viral load with respect to the duration of illness. RSV concentrations were significantly higher in children who presented earlier during their disease process and were progressively lower in children who presented later during their illness ( ) ( figure 1 ). P p .04 The levels of inflammatory mediators in nasal-wash samples were analyzed with respect to the duration of illness and the viral load. Compared with children who presented earlier or later during the course of disease, children who presented during the third or fourth day of illness had higher levels of cytokines/chemokines, although the difference was not statistically significant (data not shown). There was a significant correlation between RSV concentration in the upper respiratory tract and the levels of IL-8 (  [  ]) and IL-10 r p 0.41 P ! .01 ( [ ). With respect to prematurity, history of r p 0.35 P p .01 wheezing, or family history of wheezing, there were no significant differences in either nasal-wash RSV concentration or nasal-wash cytokine/chemokine concentrations.
Impact of age-on inflammatory mediators and on severity of bronchiolitis. Young age is a known risk factor for hospitalization for bronchiolitis; therefore, we investigated the impact that age has on the production of inflammatory mediators. Nasal-wash concentrations of cytokines/chemokines were not significantly different between the 4 age groups (data not shown), and further analysis, which adjusted for age group and the need for hospitalization, also revealed no significant difference in cytokine/chemokine concentrations. NOTE. For the majority (у88%) of children, the levels of IL-5, IL-7, IL-12, IL-13, and IL-17 were undetectable and therefore are not included in this table. G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; MCP, monocyte chemoattractant protein; MIP, macrophage inflammatory protein; TNF, tumor necrosis factor. a is considered to be significant. P р .05 Figure 1 . Prospective cohort study of children !24 months old who presented to the emergency department with signs and symptoms of bronchiolitis during a respiratory syncytial virus (RSV) outbreak. Nasalwash samples for virus isolation and RSV quantification were collected from each child at the time of presentation. The number of children in each group was 13, 25, 11, 13, and 1 for the presentation categories of 1-2, 3-4, 5-6, 7-10, and 110 days of illness, respectively. One-way analysis of variance was used to investigate the relation between the duration of illness at the time of presentation and the RSV concentration in nasal-wash samples. Viral load was most elevated in children who presented on the first or second days of illness and was progressively lower in children who presented later during the illness ( ). The P p .04 error bars represent ‫2ע‬ SE.
DISCUSSION
RSV-specific inflammatory response. The data from this prospective cohort study conducted during the RSV season indicate that, compared with children with non-RSV bronchiolitis, children with RSV bronchiolitis have an increased inflammatory response. Interestingly, both the need for hospitalization and other measures of the severity of disease were not different in RSV-positive children, compared with RSV-negative children.
Additionally, RSV concentration does not appear to be associated with the severity of disease. The data from the present study indicate that the age of a child is inversely associated with that child's need for hospitalization. Children !6 months old were significantly more likely to be RSV positive than were older children, but there was a significant positive correlation between age (in months) and RSV concentration. Collectively, these data imply that higher RSV concentrations in the upper respiratory tract are not associated with more-severe disease, because older RSV-positive children had higher RSV concentrations and were less likely to be hospitalized.
Previous investigations have established the existence of an inflammatory response associated with RSV infection, a response that is not seen in noninfected control children [12, 13, 19, 30, 31] . The data of the present study, which included both RSV-positive and RSV-negative children with bronchiolitis, show that, compared with RSV-negative children, RSV-positive children had significantly ( ) elevated levels of IL-6, IL-P р .05 8, GM-CSF, IFN-g, TNF-a, IL-1b, G-CSF, and MIP-1b. Intuitively, one would expect that this increased pro-and antiinflammatory response would cause the severity of disease associated with RSV bronchiolitis to be greater than that of the disease associated with non-RSV bronchiolitis; however, with respect to the need for hospitalization and the duration of supplemental-oxygen therapy and/or IVF therapy, there were no significant differences between the 2 groups, a finding that suggests that the greater inflammatory response associated with RSV infection may not be the dominant factor contributing to the need for hospitalization for this disease.
RSV infection, proinflammatory response, and severity of disease. The present study's analysis of RSV-infected children demonstrates that those with increased levels of proinflammatory cytokines/chemokines require less-extended supplemental-oxygen therapy, suggesting that the proinflammatory immune response plays a protective role. Previous analysis of these data from cases of RSV bronchiolitis and cases of non-RSV bronchiolitis indicated that an acute proinflammatory response was associated with less-severe bronchiolitis, and some other investigators also have demonstrated that proinflammatory mediators are elevated in children with less-severe bronchiolitis: Sheeran et al. [13] prospectively evaluated 14 intubated and 14 nonintubated children hospitalized for RSV and found a negative correlation between tracheal-aspirate RANTES, IL-8, and the severity of disease; nonintubated children had greater infiltration of nasopharyngeal inflammatory cells than did intubated children [13] . Other investigators have reported that elevated levels of IFN-g are protective against development of severe RSV bronchiolitis [9, 10, 17, 32] .
Replication of RSV has been shown to be necessary for induction of a comprehensive immune response [19, 33, 34] . In the children in the present study, the level of IL-10 was significantly inversely associated with the duration of supplemental-oxygen therapy. This cytokine has demonstrated modulatory effects for both Th1 and Th2 cytokines and plays a regulatory role in infectious and allergic processes [35] . It also is increased in response to RSV infection [36] [37] [38] [39] and has been implicated in the pathogenesis of RSV disease [36, 38] . Other investigators have shown that IL-10 inhibits viral replication [39] , and low levels of this cytokine have been found to be associated with more-severe cases of RSV bronchiolitis [13, 37] . The results of the present study have shown that levels of IL-10 are significantly higher in children who did not require prolonged supplemental-oxygen therapy, suggesting that this cytokine plays a protective role in RSV disease.
Study limitations. One of the limitations of the present study is that, because it was not feasible to obtain samples from the LRT, only nasal-wash samples were collected; however, previous studies have indicated that, in terms of both viral load [10, 11, [40] [41] [42] [43] and concentration of inflammatory mediators [32, 41] , a sample of nasal mucous is an adequate surrogate for a sample from the LRT. Another limitation is that only a single nasal-wash sample was obtained from each child and that the severity of disease was determined on the basis of whether the child required hospitalization and/or therapeutic intervention: it is possible that disease progression occurred in children who were discharged home from the ED, so the laboratory results obtained at that time may not have always been an accurate indicator of the severity of disease; although the sample size used in the present study facilitates interpretation of trends within the data, the conclusions would be strengthened if similar results were seen in repeat nasal-wash samples collected from each child.
The severity of disease was measured on the basis of both whether hospitalization was required and the duration of supplemental-oxygen therapy and/or IVF therapy; however, the sample size used in the present study limits its power to detect a difference between the RSV-positive group and the RSV-negative group-or between the group infected with the RSV A strain and the group infected with the RSV B strain-with respect to these outcomes. Nevertheless, the frequency of these outcomes across these groups was extremely consistent and supports our interpretation of the data.
Purely objective measures of outcome for bronchiolitis do not exist, necessitating the use of proxy measures of the severity of disease. The need for hospitalization, the duration of supplemental-oxygen therapy, and the duration of IVF therapy were selected as measures of severity because they represent active interventions for respiratory distress. Although it is possible that, in some children, the duration of supplementaloxygen therapy and/or IVF therapy was greater than what was truly necessary, the impact of this possibility is minimized by describing the duration of these therapies in terms of hours rather than on the basis of whether they were or were not needed.
Additionally, some infants with mild disease may have been hospitalized because of perceived increased risk of severe disease; for instance, very young infants may be hospitalized because of concern about increased risk of apnea in this age group. After enrollment in the present study was completed, the impact of this potential bias was evaluated. A total of 11 infants !2 months old who had RSV bronchiolitis were admitted to the hospital; of these 11 infants, only 2 (18%) did not have evidence of severe disease as defined by hypoxia, respiratory rate 165 breaths/min, poor air movement, or difficulty in feeding. It is likely that hospitalization of these 2 infants was based on concerns other than respiratory distress. The potential bias toward hospitalization in cases with comorbid conditions (prematurity, bronchopulmonary dysplasia, and gastroesophageal reflux) was evaluated; few of the children in the present study had a comorbid condition, and they were not significantly more likely to be admitted to the hospital. Therefore, hospital admission appears to be an appropriate outcome measure in this population. In addition, utilization of the duration of supplementaloxygen therapy and the duration of IVF therapy as additional outcome measures strengthens the conclusions.
The length of time between the acquisition and the freezing of samples could have impacted the results. All nasal-wash samples were added to transport medium with a virus stabilizer, to prevent degradation of the sample before it was processed. Linear regression analysis demonstrated that the length of time between acquisition and freezing did not impact the concentration of either RSV or IL-8. Also, virus detection was not impacted by the length of time between acquisition and processing.
CONCLUSION
The results of the present study indicate the temporal relation between RSV bronchiolitis and inflammatory response, providing insight into the evolution of this disease. Children with RSV bronchiolitis had a more robust inflammatory response than did children with non-RSV bronchiolitis, although the severity of the disease was not different between these 2 groups. Proinflammatory cytokine/chemokine concentrations, as well as IL-10 concentrations, were elevated early during the disease in children with RSV bronchiolitis who did not require sustained supplemental-oxygen therapy.
